Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Capital Expenditure

-₹3.70B

Quarterly · Period ending: · INR

RDY logo

RDY Capital Expenditure

Latest reported-₹3.70B INR
RDY Quarterly CapEx · INR (-₹130.70M → -₹3.70B)
High-resolution chart · PNG

RDY capital expenditure history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Capital Expenditure — Quarterly (INR)
Period endingCapital Expenditure (INR)
-3,702,000,000
-4,688,826,000
-7,320,000,000
-10,135,000,000
-10,147,000,000
-11,246,000,000
-8,819,000,000
-7,909,000,000
-6,424,000,000
-63,288,454
-46,037,506
-3,939,000,000
-12,171,000,000
-3,746,000,000
-3,099,000,000
-3,329,000,000
-8,690,000,000
-4,027,000,000
-4,474,000,000
-7,211,000,000
-3,337,000,000
-39,842,380
-38,935,537
-2,675,000,000
-1,891,000,000
-11,563,496
-1,380,000,000
-1,199,000,000
-1,439,000,000
-1,317,000,000
-1,730,000,000
-2,137,000,000
-2,307,000,000
-1,647,000,000
-3,340,000,000
-2,997,000,000
-3,059,000,000
-3,352,000,000
-3,098,000,000
-26,737,000,000
-7,797,000,000
-3,560,000,000
-4,837,000,000
-3,669,000,000
-2,809,000,000
-2,739,000,000
-8,000,000,000
-2,358,000,000
-2,230,000,000
-2,082,000,000
-2,647,000,000
-3,806,000,000
-2,092,000,000
-2,041,000,000
-1,639,000,000
-1,752,000,000
-1,904,000,000
-1,831,000,000
-1,470,000,000
-1,855,000,000
-3,429,000,000
-2,339,000,000
-5,303,000,000
-2,067,000,000
-1,897,000,000
-1,929,000,000
-485,000,000
-1,412,000,000
-457,000,000
-717,000,000
-1,225,038,000
-1,417,368,000
-1,401,594,000
-2,514,960,093
-1,747,637,185
-1,480,658,159
-1,026,344,563
-1,351,826,400
-1,265,517,280
-1,045,538,064
-1,084,731,027
-1,308,780,239
57,485,591
-373,671,502
-294,782,603
-551,431,108
-351,592,311
-381,273,248
-464,873,548
-629,452,287
-628,852,588
-711,353,597
-451,209,323
-451,902,163
-352,709,103
-391,271,239
-315,492,065
-379,844,939
-270,012,696
-308,590,411
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.